MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 Aug 2023 Evaluate
The sales surged to Rs. 1829.20 millions, up 39.65% for the June 2023 quarter as against Rs. 1309.88 millions during the corresponding quarter previous year.The Total Profit for the quarter ended June 2023 of Rs. 107.75 millions grew from Rs.-140.88 millionsOperating profit surged to 240.28 millions from the corresponding previous quarter of 153.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1829.20 1309.88 39.65 1829.20 1309.88 39.65 6658.98 5569.74 19.56
Other Income 18.86 29.31 -35.65 18.86 29.31 -35.65 194.31 90.03 115.83
PBIDT 240.28 153.81 56.22 240.28 153.81 56.22 1030.49 662.62 55.52
Interest 55.45 78.40 -29.27 55.45 78.40 -29.27 322.26 320.12 0.67
PBDT 184.83 75.41 145.10 184.83 75.41 145.10 1100.33 342.50 221.26
Depreciation 77.08 216.29 -64.36 77.08 216.29 -64.36 547.86 870.21 -37.04
PBT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
Equity 507.19 408.16 24.26 507.19 408.16 24.26 408.16 408.16 0.00
PBIDTM(%) 13.14 11.74 11.87 13.14 11.74 11.87 15.48 11.90 30.08
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..